These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 3732355)
1. Reduced erythropoietin levels as a cause of anaemia in patients with lung cancer. Cox R; Musial T; Gyde OH Eur J Cancer Clin Oncol; 1986 Apr; 22(4):511-4. PubMed ID: 3732355 [TBL] [Abstract][Full Text] [Related]
2. Erythropoietin in patients with anaemia in rheumatoid arthritis. Pavlović-Kentera V; Ruvidić R; Milenković P; Marinković D Scand J Haematol; 1979 Aug; 23(2):141-5. PubMed ID: 493876 [TBL] [Abstract][Full Text] [Related]
3. Role of erythropoietin in the treatment of lung cancer associated anaemia. Scagliotti GV; Novello S Lung Cancer; 2001 Dec; 34 Suppl 4():S91-4. PubMed ID: 11742710 [TBL] [Abstract][Full Text] [Related]
4. Evidence for impaired erythropoietin response to anaemia in rheumatoid disease. Boyd HK; Lappin TR; Bell AL Br J Rheumatol; 1991 Aug; 30(4):255-9. PubMed ID: 1863821 [TBL] [Abstract][Full Text] [Related]
6. EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update. Bokemeyer C; Aapro MS; Courdi A; Foubert J; Link H; Osterborg A; Repetto L; Soubeyran P; Eur J Cancer; 2007 Jan; 43(2):258-70. PubMed ID: 17182241 [TBL] [Abstract][Full Text] [Related]
7. Early intervention with epoetin beta prevents severe anaemia in lung cancer patients receiving platinum-based chemotherapy: a subgroup analysis of the NeoPrevent study. de Castro J; Belda-Iniesta C; Isla D; Dómine M; Sánchez A; Batiste E; Barón MG Lung Cancer; 2008 Feb; 59(2):211-8. PubMed ID: 17875340 [TBL] [Abstract][Full Text] [Related]
8. Chapter 8 Haemoglobin, ferritin and erythropoietin amongst UK adult dialysis patients in 2010: national and centre-specific analyses. Webb L; Gilg J; Wilkie M Nephron Clin Pract; 2012; 120 Suppl 1():c145-74. PubMed ID: 22964566 [TBL] [Abstract][Full Text] [Related]
9. The effect of subcutaneous recombinant human erythropoietin (r-HuEPO) on anemia in cancer patients receiving platinum-based chemotherapy. Malik IA; Khan ZK; Hakimali A; Sabih M; Rehman G J Pak Med Assoc; 1998 May; 48(5):127-31. PubMed ID: 9813972 [TBL] [Abstract][Full Text] [Related]
10. Level of renal function and serum erythropoietin levels independently predict anaemia post-renal transplantation. Sinnamon KT; Courtney AE; Maxwell AP; McNamee PT; Savage G; Fogarty DG Nephrol Dial Transplant; 2007 Jul; 22(7):1969-73. PubMed ID: 17353209 [TBL] [Abstract][Full Text] [Related]
11. Suboptimal endogenous erythropoietin response in chronic hepatitis C patients during ribavirin and PEG interferon treatment. Van Vlerken LG; Van Soest H; Janssen MP; Boland GJ; Drenth JP; Burger DM; Siersema PD; Van Erpecum KJ Eur J Gastroenterol Hepatol; 2010 Nov; 22(11):1308-15. PubMed ID: 20729740 [TBL] [Abstract][Full Text] [Related]
12. Erythropoietin response in anaemic patients with multiple myeloma and other lymphoid malignancies infiltrating the bone marrow. Ariad S; Clifford D; Penfold G; MacPhail AP; Bezwoda WR Eur J Haematol; 1992 Aug; 49(2):59-62. PubMed ID: 1397241 [TBL] [Abstract][Full Text] [Related]
13. Anaemia management with epoetin alfa in lung cancer patients in The Netherlands. Biesma B; van de Werf PR; Melissant CF; Brok RG Lung Cancer; 2007 Oct; 58(1):104-11. PubMed ID: 17601632 [TBL] [Abstract][Full Text] [Related]
14. Stepwise correction of anaemia by subcutaneous administration of human recombinant erythropoietin in patients with chronic renal failure maintained by continuous ambulatory peritoneal dialysis. Stevens JM; Auer J; Strong CA; Hughes RT; Oliver DO; Winearls CG; Cotes PM Nephrol Dial Transplant; 1991; 6(7):487-94. PubMed ID: 1922910 [TBL] [Abstract][Full Text] [Related]
15. Recombinant human erythropoietin in the treatment of cancer-related or chemotherapy-induced anaemia in patients with solid tumours. Nowrousian MR Med Oncol; 1998 Aug; 15 Suppl 1():S19-28. PubMed ID: 9785333 [TBL] [Abstract][Full Text] [Related]
16. EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer. Bokemeyer C; Aapro MS; Courdi A; Foubert J; Link H; Osterborg A; Repetto L; Soubeyran P Eur J Cancer; 2004 Oct; 40(15):2201-16. PubMed ID: 15454245 [TBL] [Abstract][Full Text] [Related]
17. Use of darbepoetin alfa in European clinical practice for the management of chemotherapy-induced anaemia in four tumour types: final data from the CHOICE study. Aerts JG; Swieboda-Sadlej A; Karanikiotis C; Labourey JL; Galid A; Wheeler T; Pujol B; Van Belle S Curr Med Res Opin; 2012 Jul; 28(7):1089-99. PubMed ID: 22642866 [TBL] [Abstract][Full Text] [Related]
18. Serum erythropoietin and circulating BFU-E in patients with multiple myeloma and anaemia but without renal failure. Majumdar G; Westwood NB; Bell-Witter C; Muggleston D; Phillips J; Pearson TC Leuk Lymphoma; 1993 Jan; 9(1-2):173-6. PubMed ID: 8477197 [TBL] [Abstract][Full Text] [Related]
19. Recombinant human erythropoietin in the treatment of cancer-related anaemia. Falkson CI; Keren-Rosenberg S; Uys A; Falkson G; Stevens K; Vermaak WJ Oncology; 1994; 51(6):497-501. PubMed ID: 7970493 [TBL] [Abstract][Full Text] [Related]